Literature DB >> 12812182

'Hitting you over the head': oncologists' disclosure of prognosis to advanced cancer patients.

Elisa J Gordon1, Christopher K Daugherty.   

Abstract

The disclosure of prognosis to terminally ill patients has emerged as a recent concern given greater demands for patient involvement in medical decision-making in the United States. As part of the informed consent process, American physicians are legally and ethically obligated to provide information to such patients about risks, benefits, and alternatives of all available treatment options including the use of experimental therapies. Although not legally required, the disclosure of terminal prognosis is ethically justified because it upholds the principle of self-determination and enables patients to make treatment decisions consistent with their life goals. To understand oncologists' attitudes about disclosing prognostic information to cancer patients with advanced disease, we interviewed fourteen oncologists and conducted one focus group of medical fellows. Although oncologists reported to disclose prognosis in terms of cancer not being curable, they tend to avoid using percentages to convey prognosis. Oncologists' reported reluctance to disclosing prognosis was conveyed through the use of metaphors depicting the perceived violent impact of such information on patients. Oncologists' reluctance to disclose prognosis and preserve patient hope are held in check by their need to ensure that patients have 'realistic expectations' about therapy. We discuss these data in light of the cultural, ethical, and legal dimensions of prognosis disclosure, patient hope and the doctor-patient relationship, and recommend ways to enhance the communication process.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; Professional Patient Relationship

Mesh:

Year:  2003        PMID: 12812182     DOI: 10.1111/1467-8519.00330

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  49 in total

1.  What keeps oncologists from addressing palliative care early on with incurable cancer patients? An active stance seems key.

Authors:  Timo A Pfeil; Katsiaryna Laryionava; Stella Reiter-Theil; Wolfgang Hiddemann; Eva C Winkler
Journal:  Oncologist       Date:  2014-10-31

Review 2.  Reluctance to disclose difficult diagnoses: a narrative review comparing communication by psychiatrists and oncologists.

Authors:  Alex J Mitchell
Journal:  Support Care Cancer       Date:  2007-07       Impact factor: 3.603

3.  Cancer patients' understanding of prognostic information.

Authors:  Laura A Cartwright; Levent Dumenci; Laura A Siminoff; Robin K Matsuyama
Journal:  J Cancer Educ       Date:  2014-06       Impact factor: 2.037

4.  Statin use in cancer patients with brain metastases: a missed communication opportunity at the end of life.

Authors:  Jacqueline A Mullvain; Kevin R Kozak; John S Moody; Toby C Campbell
Journal:  Support Care Cancer       Date:  2015-02-07       Impact factor: 3.603

5.  Absorbing information about a child's incurable cancer.

Authors:  Patrizia Lannen; Joanne Wolfe; Jennifer Mack; Erik Onelov; Ullakarin Nyberg; Ulrika Kreicbergs
Journal:  Oncology       Date:  2010-06-07       Impact factor: 2.935

6.  Impact of Prognostic Discussions on the Patient-Physician Relationship: Prospective Cohort Study.

Authors:  Joshua J Fenton; Paul R Duberstein; Richard L Kravitz; Guibo Xing; Daniel J Tancredi; Kevin Fiscella; Supriya Mohile; Ronald M Epstein
Journal:  J Clin Oncol       Date:  2017-11-17       Impact factor: 44.544

7.  Intended and unintended consequences: Ethics, communication, and prognostic disclosure in pediatric oncology.

Authors:  Jonathan M Marron; Angel M Cronin; Tammy I Kang; Jennifer W Mack
Journal:  Cancer       Date:  2017-12-26       Impact factor: 6.860

8.  Parental distress and desire for information regarding long-term implications of pediatric cancer treatment.

Authors:  Katie A Greenzang; Angel M Cronin; Tammy I Kang; Jennifer W Mack
Journal:  Cancer       Date:  2018-10-01       Impact factor: 6.860

9.  Communicating and understanding the purpose of pediatric phase I cancer trials.

Authors:  Melissa K Cousino; Stephen J Zyzanski; Amy D Yamokoski; Rebecca A Hazen; Justin N Baker; Robert B Noll; Susan R Rheingold; J Russell Geyer; Stewart C Alexander; Dennis Drotar; Eric D Kodish
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

10.  Resident preparedness in discussing prognosis in patients with advanced lung cancer.

Authors:  Paul Wheatley-Price; Christine Massey; Tony Panzarella; Frances A Shepherd; Joseph Mikhael
Journal:  Support Care Cancer       Date:  2009-07-21       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.